{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:53:26Z","timestamp":1768038806785,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3A9G6068246"],"award-info":[{"award-number":["2017M3A9G6068246"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2014R1A2A1A11052535"],"award-info":[{"award-number":["NRF-2014R1A2A1A11052535"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gyeonggi Provincial Government"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.antiviral.2020.104709","type":"journal-article","created":{"date-parts":[[2020,1,12]],"date-time":"2020-01-12T09:23:05Z","timestamp":1578820985000},"page":"104709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor"],"prefix":"10.1016","volume":"175","author":[{"given":"Eunji","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Kyun","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soonju","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoojin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Shick","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Cechetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc P.","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104709_bib1","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1128\/jvi.64.11.5324-5332.1990","article-title":"The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation","volume":"64","author":"Bartenschlager","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104709_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00560-17","article-title":"Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus","volume":"61","author":"Berke","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104709_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2020.104709_bib4","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1128\/AAC.46.9.3057-3060.2002","article-title":"Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro","volume":"46","author":"Delaney","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104709_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.antiviral.2017.04.012","article-title":"Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles","volume":"143","author":"Edwards","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104709_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2007.06.014","article-title":"The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging","volume":"76","author":"Feld","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104709_bib7","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0409732102","article-title":"A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly","volume":"102","author":"Finn","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2020.104709_bib9","doi-asserted-by":"crossref","first-page":"13122","DOI":"10.1128\/JVI.78.23.13122-13131.2004","article-title":"Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function","volume":"78","author":"Hu","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104709_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1073\/pnas.93.3.1060","article-title":"Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase","volume":"93","author":"Hu","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2020.104709_bib11","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/j.1460-2075.1990.tb07540.x","article-title":"A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA","volume":"9","author":"Junker-Niepmann","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104709_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/AAC.43.3.726a-726a.1999","article-title":"Erratum: inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)\u03b2-L-2\u2019,3\u2019- dideoxy-3\u2019-thiacytidine (Antimicrobial Agents and Chemotherapy (1998) 42:12 (3179-3186))","volume":"43","author":"King","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104709_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/JVI.01916-13","article-title":"Residues Arg 703, Asp 777, and Arg 781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis","volume":"88","author":"Ko","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104709_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jhep.2019.04.010","article-title":"Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells","volume":"71","author":"K\u00f6nig","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104709_bib15","first-page":"1","author":"Lam","year":"2018","journal-title":"crossm"},{"key":"10.1016\/j.antiviral.2020.104709_bib17","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/JVI.02147-07","article-title":"Inhibition of Hepadnavirus reverse transcriptase- RNA interaction by porphyrin compounds","volume":"82","author":"Lin","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104709_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JCM.00709-06","article-title":"A Genotype-Independent Real-Time PCR Assay for Quantification of Hepatitis B Virus DNA","volume":"45","author":"Liu","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104709_bib18","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1128\/jvi.70.5.2764-2773.1996","article-title":"A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis","volume":"70","author":"Nassal","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104709_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2019.02.006","article-title":"Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients","volume":"70","author":"Park","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104709_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virol.2010.07.005","article-title":"Proximity between the cap and 5\u2032 \u03b5 stem-loop structure is critical for the suppression of pgRNA translation by the hepatitis B viral polymerase","volume":"406","author":"Ryu","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104709_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2144\/000114354","article-title":"Development of a novel hepatitis B virus encapsidation detection assay by viral nucleocapsid-captured quantitative RT-PCR","volume":"59","author":"Ryu","year":"2015","journal-title":"Biotechniques"},{"key":"10.1016\/j.antiviral.2020.104709_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2007.11.010","article-title":"Hepatitis B virus polymerase suppresses translation of pregenomic RNA via a mechanism involving its interaction with 5\u2032 stem-loop structure","volume":"373","author":"Ryu","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104709_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.antiviral.2020.104709_bib24","doi-asserted-by":"crossref","first-page":"e1003125","DOI":"10.1371\/journal.ppat.1003125","article-title":"The hepatitis B virus Ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus Ribonuclease H and integrase enzymes","volume":"9","author":"Tavis","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104709_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0197664","article-title":"Rosmarinic acid is a novel inhibitor for hepatitis b virus replication targeting viral epsilon RNA-polymerase interaction","volume":"13","author":"Tsukamoto","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2020.104709_bib26","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1128\/JVI.00816-12","article-title":"Carbonyl J acid derivatives block protein priming of Hepadnaviral P protein and DNA-dependent DNA synthesis activity of Hepadnaviral nucleocapsids","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104709_bib27","series-title":"Global Hepatitis Report, 2017","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.antiviral.2020.104709_bib28","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-6700-1_15","article-title":"Detection of hepatitis B virus particles released from cultured cells by particle gel assay","author":"Yan","year":"2017"},{"key":"10.1016\/j.antiviral.2020.104709_bib29","first-page":"1","article-title":"Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219306035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219306035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:20Z","timestamp":1759062620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219306035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":28,"alternative-id":["S0166354219306035"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104709","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104709"}}